Boyles' high-octane activity, Ace Bailey's development and Cedric Coward's consistency are among the rookie achievements.

For Seahawks GM John Schneider, this week is as much about canvassing the market as it is about scouting draft prospects.

Updated data for casdatifan in late-line kidney cancer demonstrated median progression-free survival (PFS) of 15.1 months and a confirmed overall response rate (cORR) of 45% for the 100mg once-daily ...